Harrow (HROW) vs Oric Pharmaceuticals (ORIC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Oric Pharmaceuticals (ORIC) has outperformed Harrow (HROW) over the past year, losing 14.9% versus a loss of 26.9%. Over five years, HROW leads with a +209.6% price change compared with -26.0% for ORIC. Oric Pharmaceuticals is the larger company by market cap ($1.24 billion vs $1.15 billion), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HROW | ORIC |
|---|---|---|
| Share price | $30.62 | $12.01 |
| Market cap | $1.15B | $1.24B |
| 1-day change | +0.89% | +0.25% |
| YTD return | -37.51% | +46.82% |
| 1-year return | -26.92% | -14.94% |
| 5-year return | +209.61% | -26.00% |
| Forward P/E | 11.04 | — |
| EPS (TTM) | $-0.99 | $-1.32 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $54.85 | $14.68 |
| 52-week low | $28.54 | $7.23 |
| Distance from 52-week high | -44.18% | -18.19% |
| Average volume | 552.72K | 1.47M |
| Shares outstanding | 37.49M | 103.65M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ORIC has outperformed HROW by 12.0 percentage points over the past year.
HROW vs ORIC FAQ
Which is bigger, Harrow or Oric Pharmaceuticals?
Oric Pharmaceuticals (ORIC) is larger, with a market capitalization of $1.24B compared with $1.15B for Harrow (HROW).
Which stock has performed better over the past year, HROW or ORIC?
ORIC returned -14.94% over the past 12 months, compared with -26.92% for HROW (price return, excluding dividends). Past performance does not predict future results.
Are Harrow and Oric Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.